Oncology Precision Medicine Market Size, Trends, and Growth Outlook 2026-2033 The Oncology Precision Medicine industry is rapidly evolving, driven by advancements in molecular diagnostics and targeted therapies. Increasing adoption of personalized cancer treatments is reshaping patient outcomes globally. This growth is aligned with expanding research efforts and rising demand for patient-specific oncology therapeutics. Market Size and Overview The Global Oncology Precision Medicine Market is estimated to be valued at USD 153.81 billion in 2025 and is expected to reach USD 281.17 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.00% from 2025 to 2032. https://www.coherentmi.com/industry-reports/oncology-precision-medicine-market